Microbot Medical® Increases Manufacturing Capacity as Demand for the LIBERTY® System Rises; Enters into Strategic Agreement with Sanmina, a Global Manufacturing Leader

Microbot Medical entered into a Letter of Agreement with Sanmina Corporation to manufacture the LIBERTY Endovascular Robotic System, aiming to increase capacity to meet rising domestic and international demand. The partnership is expected to diversify manufacturing capabilities, improve operating efficiencies, lower costs, and expand gross margins as the company scales production.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.